Publications
128
Citations
2,595
Est. group size
~4
Recurring co-author estimate
Active years
48
Publishing since 1979
Typically publishes in teams of ~12 · 19% small-team papers (≤3 authors) · across 36 venues
- Hi-C for genome-wide detection of enhancer-hijacking rearrangements in routine lymphoid cancer biopsies
Cell Genomics · 2026
- Optical genome mapping reveals a recurrent translocation, t(14;16), in T/myeloid mixed phenotype acute leukemia: report of two cases
Molecular Cytogenetics · 2026
- Primary diffuse large B-cell lymphoma of cauda equina: a rare and challenging diagnosis
Journal of Hematopathology · 2026
- 84 Multiplex Immunofluorescence and Genomic Profiling of Epstein-Barr Virus Positive Inflammatory Follicular Dendritic Cell Tumor Reveal an Immunosuppressive Tumor Microenvironment
Laboratory Investigation · 2026
- 1251 Integrative Genomic Sequencing Reveals Differences Between EBV-Positive Mucocutaneous Ulcer and EBV-Positive Diffuse Large B-cell Lymphoma
Laboratory Investigation · 2026
- 1285 WHO5 TP53 allelic state configuration is relevant in patients with TP53 mutated myeloid neoplasms receiving hypomethylating agent (HMA)-based regimens: Interim report of the International TP53 investigators Network (iTIN)
Laboratory Investigation · 2026
- 1271 TOX2 as a Marker for T-Follicular Helper Differentiation in Normal T-Cells and T-Cell Lymphomas
Laboratory Investigation · 2026
- 1266 The 20% Blast Count Threshold is Relevant in Patients with TP53-Mutated Myeloid Neoplasm Receiving Frontline Hypomethylating Agent Based Therapies
Laboratory Investigation · 2026
- Supplementary Table S3 from Selective Enhancer Dependencies in <i>MYC</i>-Intact and <i>MYC</i>-Rearranged Germinal Center B-cell Diffuse Large B-cell Lymphoma
2026
- Supplementary Table S1 from Selective Enhancer Dependencies in <i>MYC</i>-Intact and <i>MYC</i>-Rearranged Germinal Center B-cell Diffuse Large B-cell Lymphoma
2026
- Supplementary Table S4 from Selective Enhancer Dependencies in <i>MYC</i>-Intact and <i>MYC</i>-Rearranged Germinal Center B-cell Diffuse Large B-cell Lymphoma
2026
- Supplementary Table S2 from Selective Enhancer Dependencies in <i>MYC</i>-Intact and <i>MYC</i>-Rearranged Germinal Center B-cell Diffuse Large B-cell Lymphoma
2026
- CEACAM1 expression by immunohistochemistry in B-cell lymphomas and plasma cell myeloma
American Journal of Clinical Pathology · 2026
- Nivolumab-AVD Versus Brentuximab Vedotin–AVD in Older Patients With Advanced-Stage Classic Hodgkin Lymphoma Enrolled on S1826
Journal of Clinical Oncology · 2025
- Expanding the use of T cell receptor beta constant 1 immunohistochemistry in formalin‐fixed paraffin‐embedded tissues in assessing T cell clonality in mature and immature T cell neoplasms
Histopathology · 2025
- Blood×10
- Pathology for clinicians×10
- Laboratory Investigation×10
- Archives of Pathology & Laboratory Medicine×3
- International Journal of Surgical Pathology×3
- David A. Bond
Medicine · The Ohio State University
- Beth Christian
Medicine · The Ohio State University
- Kaitlin Annunzio
Medicine · The Ohio State University
- Timothy Voorhees
Medicine · The Ohio State University
- Tycel Phillips
Medicine · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile